Nasal etripamil spray efficacy for acute paroxysmal supraventricular tachycardia: a systematic review, meta-analysis and trial sequential analysis
Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Acute paroxysmal supraventricular tachycardia (PSVT) is a common arrhythmia. Etripamil, a novel calcium channel blocker via nasal spray, has shown promise for PSVT management. This meta-analysis and trial sequential analysis (TSA) evaluates the efficacy and safety of nasal Etripamil for treat...